Alnylam Pharmaceuticals Inc (ALNY)

241.00 -4.50 (-1.83%) USD  |  NASDAQ  |  Dec 23, 10:35
More

Alnylam Pharmaceuticals Free Cash Flow Per Share (Annual)

Free Cash Flow Per Share (Annual) Chart

View Free Cash Flow Per Share (Annual) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Per Share (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Per Share (Annual) Range, Past 5 Years

View Free Cash Flow Per Share (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Per Share (Annual) Benchmarks

View Free Cash Flow Per Share (Annual) Benchmarks
Start Trial
Pfizer Inc Upgrade
BridgeBio Pharma Inc Upgrade
Gilead Sciences Inc Upgrade
Regeneron Pharmaceuticals Inc Upgrade
Sarepta Therapeutics Inc Upgrade